For Research Use Only. Not for Human Consumption.
Recorded market$69.59Recorded exact-size market estimate: 69.59 USD for one 15 mg container (4.639030 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$81.82Member price$73.63No member savings vs. this market reference
Delta sleep-inducing peptide for sleep research.
Exact-size price research
Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. This reference uses recorded prices for the same 15 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$4.91/mg
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 05:07 UTC. 1 x 15 mg = 15 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| Biotech Compounds Oct 10, 2026 UTC | One 15 mg container; 43.99 USD | $2.93/mg | powder; in_stock Primary page says /vial·15mg, selected 15mg radio and quantity one; ProductOffer USD43.99 and lyophilized powder. Regular price, bulk tiers ignored. Price observation; no COA authentication is implied by inclusion. |
| PeakForm Peptides Oct 10, 2026 UTC | One 15 mg container; 55.00 USD | $3.67/mg | powder; in_stock Selected15MG price55, estimated total1product55; product-information table FormLyophilizedPowder,Amount3mlVial5mg|15mg. USDvariantJSONLD. Quantity/checkout discounts excluded. Price observation; no COA authentication is implied by inclusion. |
| Healius Peptides Oct 11, 2026 UTC | One 15 mg container; 94.95 AUD | $4.42/mg | powder; 9instock Current94.95AUDsale114.95list;one15mgpowdervial. Price observation; no COA authentication is implied by inclusion. |
| Northline Labs Oct 10, 2026 UTC | One 15 mg container; 71.99 USD | $4.80/mg | powder; in_stock Public unconditional sale price71.99 (list79.99); quantity1 selected15mg vial. Explicit lyophilized powder. JSONLD USD. Coupon/gift excluded. Price observation; no COA authentication is implied by inclusion. |
| Your Peptide Brand Oct 10, 2026 UTC | One 15 mg container; 120.00 USD | $8.00/mg | powder; in_stock Appearance lyophilized powder in sealed research vial; no minimum for online orders,qty1 product. USD120meta/JSONLD. Price observation; no COA authentication is implied by inclusion. |
| Amino Fuel Labs Oct 10, 2026 UTC | One 15 mg container; 60.00 USD | $4.00/mg | powder; in_stock Packagecontents1×15mglyophilizedpowdervial; quantity1 price60USD public sale (100list). Emailpromo20%excluded. Price observation; no COA authentication is implied by inclusion. |
| Péptidos Colombia Oct 10, 2026 UTC | One 15 mg container; 94.00 USD | $6.27/mg | powder; listing_available_subject_to_document_validation Publicreferencequote94USDper15mgsealedpowdervialDS15;stockindicatorinitial10mgoutofstock,15mgJSONLDinStock. Institutionalquotation/availabilitysubjectdocumentvalidation,notimmediatecheckout. Price observation; no COA authentication is implied by inclusion. |
| Pepminos Oct 11, 2026 UTC | One 15 mg container; 99.00 CAD | $4.64/mg | powder; MetadataOutOfStock;bodyAddtocartpresent Public99CAD15mgsingle-usepowdervial. Availabilitysignalsconflict,donotassumeorderable. Price observation; no COA authentication is implied by inclusion. |
| Gorilla Research Labs Oct 11, 2026 UTC | One 15 mg container; 40.00 USD | $2.67/mg | powder; In stock Productspec15mgperviallyophilized40USD. Genericcalculatorappearsdefault5mgnotused;agegateunaccepted. Price observation; no COA authentication is implied by inclusion. |
| Luxe Peptides Oct 11, 2026 UTC | One 15 mg container; 75.00 USD | $5.00/mg | lyophilized powder; in stock Primary15mgProductOffer dsip-var-3 USD75 and published productvariation634displayprice75/minqty1/in_stocktrue. Productspecs explicitwhite lyophilizedpowderglassvial. Visible15mgradiocheckedbut frontendpricepanelremainsrange; nativehiddenselectdidnotsync. Representativephoto5mg, affirmative15mgspec/Offer/variantmatch; no scaling. Buy2get1promoignored, singlequantity1; no entrygate. Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “DSIP – 15 mg | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/dsip-15-mg/ Accessed [your access date].
Source page: https://peptideserum.com/product/dsip-15-mg/
A nonapeptide first isolated in sleep research, used in studies of sleep architecture and stress-axis signaling.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
Delta sleep-inducing peptide, or DSIP, has been investigated for effects on sleep and other physiological responses. Small, older human studies are more relevant than the name alone: calling a substance “sleep-inducing” does not establish reliable insomnia treatment or a predictable nightly effect.
Keep synthetic DSIP administration separate from measurements of DSIP-like material in the body. Observing a peptide signal is not the same experiment as giving a defined preparation.
Sleep studies, withdrawal reports and animal experiments ask different questions. Combining them into a single success rate would conceal their different populations, designs and outcomes.
One checked crossover experiment included six healthy volunteers, while a withdrawal report described physician- and nurse-assessed outcomes in inpatients. These are historical signals that justify careful examination, not a modern evidence base for a self-directed sleep or withdrawal regimen.
| Study and design | Finding | What it does not establish |
|---|---|---|
| DSIP and sleep in six volunteers
Double-blind crossover experiment in healthy adults Reading scope: PubMed abstract |
The investigators reported acute sleep changes and some subsequent-night sleep changes after supervised intravenous administration. | Six volunteers and short observation cannot establish sustained insomnia benefit, optimal exposure or uncommon harms. |
| DSIP in alcohol and opiate withdrawal
Inpatient clinical report with staff assessments Reading scope: PubMed abstract |
The report described symptom improvement in evaluable patients after DSIP administration. | The abstract does not describe a randomized placebo comparison; exclusions and subjective assessments limit causal conclusions. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
Healthy-volunteer sleep measurements do not automatically apply to chronic insomnia, sleep apnea, a circadian disorder or medication-related sleep problems. A useful trial would specify the diagnosis and compare meaningful outcomes such as daytime function as well as sleep recordings.
The withdrawal report is particularly easy to overread. Clinical improvement during monitored inpatient care cannot be assigned to a peptide without accounting for other care, timing, selection and a comparator. Its percentages should not become a consumer response-rate badge.
Short-term tolerability and clinical usefulness are different questions. Even a reproducible change in sleep timing would leave the balance of daytime effects, repeated use and longer-term outcomes unresolved.
The small studies cannot exclude uncommon or delayed problems. The withdrawal report mentioned headaches. It should not be used to substitute a peptide for established, supervised care for alcohol or opioid withdrawal.
The historical intravenous research is described to identify study context. It does not establish a nightly schedule, a reconstitution recipe or equivalence with other routes.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Check the exact peptide identity and formulation. A seller should not use an unrelated sleep supplement trial, a DSIP biomarker paper or a withdrawal success percentage as proof for a particular vial.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
No. The relevant evidence is the measured result in a specified study. A compound name is not an outcome, and a small experiment cannot predict every user’s response.
No. Route and formulation can change exposure. Those preparations require their own evidence rather than borrowing a result from another delivery method.
This companion to the DSIP (Delta Sleep-Inducing Peptide) research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
The historical intravenous research is described to identify study context. It does not establish a nightly schedule, a reconstitution recipe or equivalence with other routes.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Read the full DSIP (Delta Sleep-Inducing Peptide) profile and sources
Reviews
There are no reviews yet.